Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Trevor Clark Austin"'
Autor:
Kalyan Mantripragada, Kenneth D. Bishop, Kayla Rosati, Lynn Shaw, Trevor Clark Austin, Kristen Mitchell, Kimberly Perez, Lindsay Houlihan, Alise Lombardo, Howard Safran, Kevin P. Charpentier, Diane Martel
Publikováno v:
Journal of Clinical Oncology. 32:4123-4123
4123 Background: The contribution of irinotecan to the efficacy of FOLFIRINOX in pancreatic cancer is uncertain. The addition of irinotecan to gemcitabine was not superior to gemcitabine alone in p...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90ab31f098486e8422448a3f7cae0f34
https://doi.org/10.1200/jco.2014.32.15_suppl.4123
https://doi.org/10.1200/jco.2014.32.15_suppl.4123
Autor:
Kayla Rosati, Lindsay Houlihan, Kevin P. Charpentier, Lucia Fontes-Borts, Irene Kolberg, Kristen Mitchell, Omar Nadeem, Kalyan Mantripragada, Alise Lombardo, Trevor Clark Austin, Kimberly Perez, Howard Safran
Publikováno v:
Journal of Clinical Oncology. 32:258-258
258 Background: FOLFIRINOX improves survival in advanced pancreatic cancer, however the contribution of irinotecan is uncertain. The addition of irinotecan to gemcitabine was not superior to gemcitabine alone in pancreatic cancer, however nab-P demon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::190a30aeb360339c0df57ca75094b7eb
https://doi.org/10.1200/jco.2014.32.3_suppl.258
https://doi.org/10.1200/jco.2014.32.3_suppl.258
Autor:
Kimberly Perez, Howard Safran, Lucia Fontes-Borts, Denise Luppe, Kayla Rosati, Maureen Jean, Adam J. Olszewski, Trevor Clark Austin, Bharti Rathore
Publikováno v:
Journal of Clinical Oncology. 31:e15095-e15095
e15095 Background: Cabazitaxel is a semi-synthetic novel taxane with activity in docetaxel refractory prostate cancer. We sought to determine the response rate of cabazitaxel in patients with advanced gastroesophageal adenocarcinoma that had progress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f4bb10788a6e9d398dfc1a66bae5d32
https://doi.org/10.1200/jco.2013.31.15_suppl.e15095
https://doi.org/10.1200/jco.2013.31.15_suppl.e15095
Autor:
Trevor Clark Austin, Maureen Jean, Matthew Vrees, Nishit Shah, Adam Klipfel, Thomas A. DiPetrillo, Kimberly Perez, Kayla Rosati, Denise Luppe, Howard Safran
Publikováno v:
Sexual Health. 10:588
Background Human papillomavirus (HPV) DNA is present in the majority of squamous cell cancers of the anus. ADXS11–001 immunotherapy is a live attenuated Listeria monocytogenes (Lm) bioengineered to secrete an HPV-16-E7 fusion protein targeting HPV-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e4e3d97191277187c697b3cc3e488c5
https://doi.org/10.1071/shv10n6ab37
https://doi.org/10.1071/shv10n6ab37